{"name":"Bold Therapeutics, Inc.","slug":"bold-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"Bold Therapeutics, Inc. is a biotechnology company focused on developing innovative treatments for cancer. The company's lead candidate, BOLD-100, is currently being evaluated in Phase 1 clinical trials in combination with FOLFOX chemotherapy.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE9kSDVVSzJvX21KZXRGZkVXTDNkdnhWem51YlRCdFNOSWpVdmRvMmhnZl8xbjJlV2F0MHZjV1JVWW5RWlZIYjd1V0h5Rm1QTVZHX2FsMlJBcVhONGE2RnRsSFNoemRMclJJbTQydzZqTk9QUmhoaEwxWjB1SDhxUjA?oc=5","date":"2026-03-25","type":"pipeline","source":"Rolling Out","summary":"Merck makes bold $5.7 billion bet on Terns Pharmaceuticals - Rolling Out","headline":"Merck makes bold $5.7 billion bet on Terns Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQVWZiU0J2RUZBTVNTdzRvNmN2UGhrMm4xbHM4RWw5TU91TlFDWlZ1alF0ZHcycFYwbkdWVkFKX1pwNm01SjBNTXU3ZUlxU1ZVWFRhNHZhU295MkJmbmNVZ0tweFEtTmRRdVI5NHhDOTVpMFN5dnZBcVk0ekVEVDQ0MlF6a04yZG1kWmNR?oc=5","date":"2026-03-02","type":"regulatory","source":"Yahoo Finance","summary":"Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight - Yahoo Finance","headline":"Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (202","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTFBsX2RhWXU4LXFtNVM1REt1NWdqeWE5RlJ3MVltRUZvUEFJUW9OZ0hPTWpVWk1wN3FHcF9kOHhCN2d3d1BMN21tX3I0TXRpSjE3YmVWUUtjdGN6a3FISzVKanNVQmItX0JJa2F3?oc=5","date":"2026-01-14","type":"pipeline","source":"Pharmabiz.com","summary":"Amneal unveils bold new brand to reimagine what’s possible in making medicine accessible for all - Pharmabiz.com","headline":"Amneal unveils bold new brand to reimagine what’s possible in making medicine accessible for all","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNazh2WTVKU1lfWmVSNjRONVFmTUh1TDZycU5CSGU0Q3ZCSW4yM0VONjktemk2QlRhdFFPaUFFdW5zQjZXWmxNaFcySlFTc05DRFVQcjg2b1pyYk1EbG92cDZWTXNkalJENGZ1bnRGTl9jUDBJMFVXa2hrbllyTkoxQ05HUEswZUtXNk16TmhvNWJvdG1RWXVINQ?oc=5","date":"2026-01-09","type":"pipeline","source":"PwC","summary":"Future of Pharma: Breakthroughs at Scale - PwC","headline":"Future of Pharma: Breakthroughs at Scale","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQdXpsci1KLWdkeURFT2g4NkZEX2RpZEZ5OXMxWE1hcEJnMFd2NlZLRXhuejJuWWlmUmhveHRpeFpYVXgwbG5JMk9fTTBjbDNfWFFwRkljY0VQQkVJMW1HeXVKWDRHYVJvQ2Q2a1k2N0Fhc2ZCQzJTbDRoZTViTGloLTd2WUlKdUdtOGF2Rk1lcEJsb0VfMXJR?oc=5","date":"2025-12-16","type":"pipeline","source":"The Motley Fool","summary":"1 Bold Prediction for Viking Therapeutics in 2026 - The Motley Fool","headline":"1 Bold Prediction for Viking Therapeutics in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQT3dhQVJaOEh3V1ZNUS1uR0c4MlpSUG1WSVlSUVdoOTVLa2d1djQwNmdzT3BQaXE5a25rN2RLTU1nZGtsV1lhYzhINFB3a2t5SmhfVTZQd1JZSjQ0YzZWRml0TllVOHdnVnlFNzNBaFRvR1RBNEF0VUNYMUJhZl9CZ3FWTi0?oc=5","date":"2025-12-03","type":"deal","source":"Yahoo Finance","summary":"GE HealthCare and Mayo Clinic unveil GEMINI-RT: A bold research collaboration in radiation therapy and advanced cancer care - Yahoo Finance","headline":"GE HealthCare and Mayo Clinic unveil GEMINI-RT: A bold research collaboration in radiation therapy and advanced cancer c","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNQzZGQy1NRWNPMmk1YUE3SDY4Vm5wLUJ3UlhKQmY2NVhWRk5mbXRyTHBZMUM5YmlZczgxZGtmZVFMcXdrTE5wdGYyZGxFQnpxYkZwM1FKM3VPRHhPbVJqOE10N25RU3ByTUpUYjJvNGU0WVFRS3dISFUxWEtSQU5vQlNiNllBeEtJdzR2a1FWaWRjRWRvX3NxcC03d2dVYUJnVkIxaF8zbzhyTWhVQ1ZqazdXdm43WTlMRjlQNW5B?oc=5","date":"2025-07-23","type":"pipeline","source":"McKinsey & Company","summary":"Bold moves, bolder vision: A CEO’s path for innovative pharma - McKinsey & Company","headline":"Bold moves, bolder vision: A CEO’s path for innovative pharma - McKinsey & Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwJBVV95cUxPSlFhcVdwaFlONm5LenM3akJpY2hmc04zT3hMeWFVMm50ZTBMTWNZNlFWRFBUOUdJZ010blhQNkpKR1gzd2NwN0lDOXFRQlFQVmZZSW82aDRiYU94a3VaZDkxWWsxTWJGUEJlNnJWa1pGV2FEZkFLX3QyVWJJSDQ2ajgxZnVQY25wZnloZ3RBOVR4RGhSZ1REYjhHWGhzeTlmVjFmbEQ5b1ZSTktKQzltVDM0bHdBNm1DSEM2S1VSbEl0a0QybjUzZE5laFF2YTFqSkZNYlVrdXBKQm9lVjlZTTZiSDMwa3YzMUgwaHAxeV82LVNKZTFoZUI5ZG1NbThqUlE5bEFBUWJ6Rm5XcVV5Q2VWNl9NREdCN2lycUhOU2otUEh6NDBmSERtS3VPaENoMnI3M0tKRmxmTjg?oc=5","date":"2025-05-13","type":"trial","source":"GlobeNewswire","summary":"Metastatic Colorectal Cancer Clinical Trial Pipeline - GlobeNewswire","headline":"Metastatic Colorectal Cancer Clinical Trial Pipeline","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivwJBVV95cUxQVENNSV9uVkRBdjVpOE5jSS1qcU5uZHhYUWYyN056dWxGXzNyVHhUc2hCNDZneHFjMU93Z3U5Znl6VDV6TF9VcWpXYnhKb1o4blhlTWRVXzJWQnRJTDFpeE1HWUI5QldXU3pwX0MyS3MyWXRtOVBmandDM0dCODdOa3JERWxfSGVOX2hvU09TWVd6aDdDakRYS3EzR2cwTzZVTkVlRm1ISll5ZmZRYlRfTjFpRG5TTTJWb3dMUkpFc3gtSktiQkd4VFhzVmRSUWl1Uk5TQnMzSFVaWEdHSi14bGtMX3lwY1JWZlFqSEVSSVhrSDQzTUdtbWpHQjRFdURvNGctNUkzeUV4emdtNjZOdFRPNWk1WXJieFhnbG0tN3NFQXVTak1aOUEyc2FLZ1NZel9PYjVLMlpFcmRDWGhJ?oc=5","date":"2025-04-30","type":"pipeline","source":"PR Newswire","summary":"Bold Therapeutics Presents Late-Breaking Poster on BOLD-100's Unique Ability to Mitigate Oxaliplatin-Induced Peripheral Neuropathy (OIPN) at AACR Annual Meeting 2025 - PR Newswire","headline":"Bold Therapeutics Presents Late-Breaking Poster on BOLD-100's Unique Ability to Mitigate Oxaliplatin-Induced Peripheral ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxOTFJ5ZVlpMjBjOWZJS3RPdkpObmFnTkdWai1ZYXhnRENNY3dGUk1RLUNSZWplbnB5YWJLWlpGd3gwSDk4SVIxTUZHeFRYZHVQS1RfZ2lEQXpnQ2NZdjY2RHhXQ0RnMWtDbnFFVWRZVnVxY0pEakxGa3NiVVpkWmxZSTR2R0xReWNpc3RrRkpYRzVWLVFDUGZZbmpMLVJSYUl2UGxTVEhvay1JQk1MRGh6OWJXU1ZhOHZOUjEtU3dKam1hcHlSSS1USkZxNUd4LTlQZDFJci0yR3FDLUU3aHhEckdKTXp6eG80aHFGNDg2alJrUkFraDlNcEsyNk43TWYwZElRQmZvNlViRldUVm9zRG85UGFpU2U0bVhieXluTlI3ZzBzZU8yaEVyMm1Tdw?oc=5","date":"2025-04-28","type":"trial","source":"PR Newswire","summary":"Bold Therapeutics Announces Presentation of Late-Breaking Data on BOLD-100's Unique Ability to Mitigate Oxaliplatin-Induced Peripheral Neuropathy (OIPN) - PR Newswire","headline":"Bold Therapeutics Announces Presentation of Late-Breaking Data on BOLD-100's Unique Ability to Mitigate Oxaliplatin-Indu","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE5FUko5VWM3NW1majZ6ZEMzaVdHa0g3aEJERzRRYzlYZHRxblBLSmFPMFNGOFdwWHFsMGFZV1VCMnlSM216WmVDLW91MERGaThiSWpXX2luOHExRXE1U2huTW9vOXZlU0FSdXljRDgwU293d0NnQkNINnkwdThNNHM?oc=5","date":"2024-09-19","type":"pipeline","source":"The Pharma Letter","summary":"GCTx launches with bold cell therapy claim - The Pharma Letter","headline":"GCTx launches with bold cell therapy claim","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE00NExmdjllS1pxOEZaVk8wNWJyUVpRMkNfRG50NmkzejdkWlZZOEUtRC1WU2Q0UnFIcXlvR2FNeWpsLUdWYUpSTWozYmVSMnpWbnZiVlpJRHpUb3piQ2kzUHJyeldudmxEdjBrRThRVnNTdlRBQ3Vwb2c2aGZUQQ?oc=5","date":"2023-09-20","type":"pipeline","source":"BioSpace","summary":"10 Promising Therapies for Hard-to-Treat Cancers - BioSpace","headline":"10 Promising Therapies for Hard-to-Treat Cancers","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}